2014 Analysis of Enteric Diseases in Italy: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Japan: Market Outlook and Emerging Opportunities
US$ 2,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Spain: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in the UK: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in the US: Market Outlook and Emerging Opportunities
US$ 3,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of the French Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 508 pages, 67 tables and presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
508 pages
2014 Analysis of the German Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
523 pages
2014 Analysis of the Italian Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 521 pages, 63 tables and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
521 pages
2014 Analysis of the Japanese Hospital Clinical ChemistryAnd Immunodiagnostics Market
US$ 3,880.00
This new report from Venture Planning Group contains 520 pages, 64 tables and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
520 pages
2014 Analysis of the Spanish Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 514 pages, 63 tables and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
514 pages
2014 Analysis of the UK Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...
November 2013
523 pages
2014 Analysis of the US Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 6,240.00
This new report from Venture Planning Group contains 543 pages, 63 tables and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...
November 2013
543 pages
2014 Analysis of the US Hospital Infectious Disease Testing Market
US$ 5,440.00
This new report from Venture Planning Group contains 997 pages, 87 tables and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
997 pages
2014 Analysis of the French Hospital Infectious Disease Testing Market
US$ 3,560.00
This new report from Venture Planning Group contains 897 pages, 77 tables and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
897 pages
2014 Analysis of the German Hospital Infectious Disease Testing Market
US$ 3,560.00
This new report from Venture Planning Group contains 897 pages, 74 tables and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
897 pages
2014 Analysis of the Italian Hospital Infectious Disease Testing Market
US$ 3,560.00
This new report from Venture Planning Group contains 887 pages, 72 tables and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social ...
November 2013
887 pages
2014 Analysis of the Japanese Hospital Infectious Disease Testing Market
US$ 4,640.00
This new report from Venture Planning Group contains 891 pages, 75 tables and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social ...
November 2013
891 pages
2014 Analysis of the Spanish Hospital Infectious Disease Testing Market
US$ 3,560.00
This new report from Venture Planning Group contains 880 pages, 73 tables and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social ...
November 2013
880 pages
2014 Analysis of the UK Hospital Infectious Disease Testing Market
US$ 3,560.00
This new report from Venture Planning Group contains 886 pages, 67 tables and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
886 pages
2014 Analysis of the French Hospital Tumor Marker Testing Market
US$ 3,080.00
This new report from Venture Planning Group contains 533 pages, 43 tables and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
533 pages
2014 Analysis of the German Hospital Tumor Marker Testing Market
US$ 3,080.00
This new report from Venture Planning Group contains 530 pages, 40 tables and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
530 pages
2014 Analysis of the Italian Hospital Tumor Marker Testing Market
US$ 3,080.00
This new report from Venture Planning Group contains 525 pages, 38 tables and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
525 pages
2014 Analysis of the Japanese Hospital Tumor Marker Testing Market
US$ 3,880.00
This new report from Venture Planning Group contains 537 pages, 42 tables and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
537 pages
2014 Analysis of the Spanish Hospital Tumor Marker Testing Market
US$ 3,080.00
This new report from Venture Planning Group contains 521 pages, 41 tables and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
521 pages
2014 Analysis of the UK Hospital Tumor Marker Testing Market
US$ 3,080.00
This new report from Venture Planning Group contains 527 pages, 37 tables and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
527 pages
2014 Analysis of the US Hospital Tumor Marker Testing Market
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
November 2013
567 pages
2014 Strategic Analysis of Major Blood Banking Product Suppliers
US$ 1,960.00
This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, ...
November 2013
50 pages
2014 analysis of the Global Enteric Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers
US$ 9,200.00
... -page report from Venture Planning Group contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, ... of leading suppliers. About This Report This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, ...
November 2013
389 pages
2014 Analysis of the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players
US$ 7,880.00
... report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, ... of leading suppliers. About This Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, ...
November 2013
366 pages
2014 Analysis of the Global Sexually-Transmitted Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review,Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players
US$ 7,680.00
... page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging ... , and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain ...
November 2013
350 pages
2013 Analysis of the Toxoplasmosis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
US$ 3,480.00
The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... presents sales and market share estimates for major suppliers of Toxoplasmosis tests. Also, the report examines the market applications of DNA ...
November 2013
226 pages
2014 Analysis of the Adenovirus Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
US$ 3,480.00
The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... report presents sales and market share estimates for major suppliers of Adenovirus tests. Also, the report examines the market applications of DNA ...
November 2013
205 pages
2014 Analysis of the Aeromonads Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
US$ 3,480.00
The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by ...
November 2013
200 pages
2014 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
US$ 4,360.00
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ... the 5- and 10-year test volume and sales forecasts by country for HIV-1/2, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in ...
November 2013
2014 Analysis of the Lime Disease Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
US$ 3,480.00
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales ...
November 2013
203 pages
